BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang J, Shen Z, Song Z, Luan J, Li Y, Zhao T. Drug Response Associated With and Prognostic lncRNAs Mediated by DNA Methylation and Transcription Factors in Colon Cancer. Front Genet 2020;11:554833. [PMID: 33329694 DOI: 10.3389/fgene.2020.554833] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Neary B, Lin S, Qiu P. Methylation of CpG Sites as Biomarkers Predictive of Drug-Specific Patient Survival in Cancer. Cancer Inform 2022;21:117693512211311. [DOI: 10.1177/11769351221131124] [Reference Citation Analysis]
2 Hu C, Xu Y, Li F, Mi W, Yu H, Wang X, Wen X, Chen S, Li X, Xu Y, Zhang Y. Identifying and characterizing drug sensitivity-related lncRNA-TF-gene regulatory triplets. Brief Bioinform 2022:bbac366. [PMID: 36007239 DOI: 10.1093/bib/bbac366] [Reference Citation Analysis]
3 Su M, Tang J, Yang D, Wu Z, Liao Q, Wang H, Xiao Y, Wang W. Oncogenic roles of the lncRNA LINC00460 in human cancers. Cancer Cell Int 2022;22:240. [PMID: 35906593 DOI: 10.1186/s12935-022-02655-2] [Reference Citation Analysis]